Clinically reviewed by Khali Reed, CRNA, APRN
Publisher Brazelia MedSpa & Integrative Wellness
How we sourced this page
Weight Maintenance Boca Raton: Planning the Year After the Result
Planning weight maintenance Boca Raton patients can actually hold begins with a number almost nobody is shown at the start: what happened in the trial that tested stopping. It is in the approved labeling, it is unambiguous, and it is the single most useful thing to understand before a first injection rather than after a twelfth.
The tirzepatide label reports a trial built to answer this. Everyone took the medicine openly for 36 weeks. Then 670 of them were randomised either to continue or to switch to placebo for another 52 weeks. Those who continued lost a further 5.5%. Those who stopped gained 14.0%.
That is why the approved indication itself contains the words “maintain weight reduction long term”. This is a long-term treatment in the same sense that blood pressure medicine is, and a programme that does not discuss the second year at the first appointment is selling you the first year only.
Weight maintenance Boca Raton: what the withdrawal trial recorded
Most weight loss content stops at the headline reduction. The labeling does not, and the trial it does not stop at is the one that should shape your expectations.
In Study 4 of the tirzepatide label, every participant took the medicine openly for 36 weeks first, so everyone arrived at the randomisation point having already lost weight. Then 670 of them were split: continue, or switch to placebo, for 52 more weeks.
| Group | Next 52 weeks |
|---|---|
| Continued treatment | lost a further 5.5% |
| Switched to placebo | gained 14.0% |
Two things follow for anyone thinking about weight maintenance. The first is that the result was still improving at 36 weeks — the continuing group kept going. The second is that stopping did not hold the line; it reversed it. This is a treatment that works while it is being taken, which is an ordinary property of medicines and an extraordinary surprise to anyone who was sold a finish line.
What the approved indication actually says about this
The FDA wording is explicit. Tirzepatide is indicated to “reduce excess body weight and maintain weight reduction long term” in the populations it covers. Maintenance is not a phase somebody added afterwards; it is inside the sentence the drug was approved on.
The semaglutide label carries the same logic across its indications, including one for reducing cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight — an indication that only makes sense as an ongoing treatment. That trial followed 17,604 patients for a median of 41.8 months and reported a hazard ratio of 0.80 for major adverse cardiovascular events.
It is worth saying plainly, because the alternative framing does real harm to weight maintenance. People who believe they are taking a course of something, and then regain weight when the course ends, generally conclude they failed. The labeling says otherwise, and knowing that in month one rather than month eighteen changes how the whole thing feels.
What a maintenance plan actually contains
A maintenance plan is not a document handed over at the end. It is a set of decisions made early and revisited, and it has four parts. Each one is about holding a weight reduction rather than producing one.
What the medication does next. Whether you continue, and at what dose, is a clinical decision made with you rather than a default. The tirzepatide label lists 5 mg, 10 mg and 15 mg as maintenance doses for weight reduction, and 5 mg on its own recorded a 15.0% mean reduction over 72 weeks. Where you settle is discussed against how you are responding, not chosen in advance.
What gets measured. The same four measures used during the reduction — waist, weight, strength and the metabolic markers on the metabolic labs page — keep being taken, because drift is easiest to correct while it is still small.
What you built. The protein, the structure and the two resistance sessions a week that the federal guidelines ask for do not stop being relevant. They are the part of the plan that does not depend on a prescription, and they were built during the window when building them was easiest.
What happens if something changes. Cost, side effects, supply, life. Deciding in advance what a pause would look like, and what would be watched during one, is more useful than improvising it later.
How maintenance is handled at Brazelia MedSpa
The weight maintenance conversation happens at the first appointment. Not because it is pleasant to open with the year-two question, but because the alternative is a patient discovering the withdrawal data by regaining weight.
Review continues after the weight reduction does. That is the part most programmes quietly drop, and it is the part the trial evidence says matters, because the group that stopped in Study 4 did not plateau — they went the other way, and quickly.
Because Brazelia MedSpa is run by the same people every visit, the second year is with the clinicians who saw the first. That is worth more on a treatment measured in years than on one measured in an afternoon, and it is the main reason people stay with a programme long enough for maintenance to be a real thing rather than a word.
New patients start with a consultation, where what the first year and the second would both look like is discussed before anything is prescribed.
Frequently asked questions
What happens if I stop taking it?
The tirzepatide label reports a trial designed for that question. After 36 weeks of treatment, 670 people were randomised to continue or switch to placebo for 52 weeks. Those who continued lost a further 5.5%. Those who stopped gained 14.0%. Source 1.
So do I have to take it forever?
The approved indication covers maintaining weight reduction long term, and the evidence says the effect depends on continuing. Whether you continue, at what dose, and what a planned pause would involve are clinical decisions made with you rather than a policy we apply. Sources 1 and 2.
Can I stay on a lower dose to maintain?
The label lists 5 mg, 10 mg and 15 mg as maintenance doses for weight reduction, and 5 mg on its own recorded a 15.0% mean reduction over 72 weeks in the main trial. Where you settle is decided against how you respond. Source 1.
Does keeping up the diet and exercise prevent regain?
Nothing in the labeling tests that, so we will not claim it. What the record does show is that the work produced real results on its own in the semaglutide trial where placebo patients also received intensive support, and it is the part of the plan that does not depend on a prescription. Sources 1 and 2.
Why does the heart indication matter for maintenance?
Because it only makes sense as an ongoing treatment. That indication rests on 17,604 patients followed a median of 41.8 months, with a hazard ratio of 0.80 for major cardiac events, and it reframes the medicine as something you take for a reason beyond the scale. Source 2.
When should maintenance be discussed?
At the first appointment. The alternative is finding out about the withdrawal data by living it, which is how people end up believing they failed at something that was working exactly as the label describes. Sources 1 and 2.
Sources and how this page was built
The withdrawal figures and dosing on this page are read from the FDA-approved labeling for tirzepatide, and the cardiovascular and lifestyle figures from the labeling for semaglutide, both on 28 September 2026. Approved indications are quoted in the FDA’s wording. Where the labeling does not test a question, this page says so rather than answering it anyway.
- FDA. Zepbound (tirzepatide) injection, prescribing information, revised 01/2026. accessdata.fda.gov
- FDA. Wegovy (semaglutide) injection, prescribing information, clinical studies section. accessdata.fda.gov
- HHS. Physical Activity Guidelines for Americans, 2nd edition, Key Guidelines for Adults. odphp.health.gov
- NIDDK. Diabetes Tests & Diagnosis, National Institute of Diabetes and Digestive and Kidney Diseases. niddk.nih.gov
- NHLBI. Metabolic Syndrome — Diagnosis, National Heart, Lung, and Blood Institute. nhlbi.nih.gov
Why patients choose Brazelia MedSpa
This page is the best answer we can give. The withdrawal trial is the number a clinic has every commercial reason to leave out, because it makes the first appointment harder. It is on this page in a table, because a programme that only works while you do not read the label is not a programme worth joining.
Weight management at Brazelia MedSpa is run by Khali Reed, CRNA, APRN, in a practice under the medical direction of Dr. Herbert R. Slavin, MD, on site rather than a name on a licence. Prescription weight management is medicine, and it is treated here as medicine rather than as a product.
Brazelia MedSpa has treated patients from the same address in downtown Boca Raton for 18 years, near Mizner Park, and sees patients from across South Florida, from Delray Beach and Boynton Beach to Deerfield Beach and Fort Lauderdale. The programme is run by the same people every visit, which matters more on a medication you take for a year than on a treatment you have once.
Weight is also rarely treated as just weight here. Because Brazelia MedSpa runs hormone, metabolic, skin and regenerative programmes under one roof, thyroid, sleep, training load and the skin changes that follow a large weight reduction can be looked at in the same place, by people who are already talking to each other.
New patients start with a consultation, and nothing is prescribed on a first visit unless it is clinically appropriate and you want to proceed. You will hear what the label supports, what it does not, and what the plan would look like before anything is decided.
This page describes what published labels, regulatory records and peer-reviewed research report about these treatments. It is general health information, not medical advice, and it is not a substitute for a consultation. Whether any treatment is appropriate for you is a clinical judgement that depends on your history and examination.
Plan the second year in Boca Raton, not just the first
New patients start with a consultation, where what the first year and the second would both look like is discussed before anything is prescribed.